|
Index of reports
> Cases resulting in death (25)
> Cases with Pulmonary Hypertension (5)
Below is the selection of adverse event reports related to Cozaar (Losartan) that includes cases resulting in death where reactions include pulmonary hypertension.
Adverse event in receiving Cozaar (Losartan)
Reported by a consumer/non-health professional from France on 2007-02-05
Patient:
Adverse reactions / side effects: Pulmonary Hypertension, Right Ventricular Failure, Dyspnoea, Hypotension, Electromechanical Dissociation, Renal Failure, Cyanosis, Hypoxia, Hypertension, Shock, Venous Occlusion
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Altace
Dosage: 10 mg, qd
Administration route: Oral
Cozaar
Dosage: 1 u, qd
Administration route: Oral
Detensiel / 00802601 /
Dosage: 10 mg, qd
Administration route: Oral
Rapamune
Dosage: 4 mg, qd
Administration route: Oral
End date: 2006-12-09
Lercan
Dosage: 1 u, qd
Administration route: Oral
End date: 2006-12-09
Cellcept
Dosage: 1000 mg, qd
Administration route: Oral
Start date: 2005-07-16
End date: 2006-12-09
Other drugs received by patient: Luteran
Adverse event in 19 year old female receiving Cozaar (Losartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-02-01
Patient: 19 year old female
Adverse reactions / side effects: Pulmonary Hypertension, Right Ventricular Failure, Venoocclusive Disease, Blood Pressure Decreased, Electromechanical Dissociation, Renal Failure Acute, Shock
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Rapamune
Dosage: 4 mg total daily
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-07-16
Cozaar
Administration route: Oral
End date: 2006-01-01
Triatec
Administration route: Oral
End date: 2006-01-01
Cellcept
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-07-16
Detensiel
Administration route: Oral
End date: 2006-01-01
Lercanidipine Hydrochloride
Administration route: Oral
Other drugs received by patient: Luteran
Adverse event in 19 year old female receiving Cozaar (Losartan)
Reported by a individual with unspecified qualification from France on 2007-01-25
Patient: 19 year old female
Adverse reactions / side effects: Pulmonary Hypertension, Right Ventricular Failure, Electromechanical Dissociation, Renal Failure, Venoocclusive Disease, Blood Pressure Decreased, Hypertension, Shock
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Bisoprolol Fumarate
Dosage: 1 dosage, oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Cozaar
Dosage: 1 dosage, oral
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Adverse event in 19 year old female receiving Cozaar (Losartan)
Reported by a consumer/non-health professional from France on 2007-01-23
Patient: 19 year old female
Adverse reactions / side effects: Pulmonary Hypertension
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Cellcept
Dosage: dosage regimen reported as 2 doses in the morning and 2 doses in the evening.
Administration route: Oral
Indication: Renal Transplant
Start date: 2005-07-16
End date: 2006-12-09
Triatec
Dosage: dosage regimen reported as one dose in the morning and one dose in the evening.
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Lercan
Dosage: dosage regimen reported as one dose in the morning.
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
End date: 2006-12-09
Rapamune
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Start date: 2005-07-16
End date: 2006-12-09
Detensiel
Dosage: dosage regimen reported as one dose in the morning.
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Cozaar
Dosage: dosage regimen reported as one dose in the morning.
Administration route: Oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Luteran
Adverse event in 19 year old female receiving Cozaar (Losartan)
Reported by a health professional (non-physician/pharmacist) from France on 2007-01-11
Patient: 19 year old female
Adverse reactions / side effects: Pulmonary Hypertension, Cyanosis
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Cozaar
Administration route: Oral
Indication: Hypertension
End date: 2006-12-01
Bisoprolol Fumarate
Administration route: Oral
Indication: Hypertension
End date: 2006-12-01
Sirolimus
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-07-16
End date: 2006-12-01
Lercanidipine
Administration route: Oral
Indication: Hypertension
End date: 2006-12-01
Ramipril
Administration route: Oral
Indication: Hypertension
End date: 2006-12-01
Mycophenolate Mofetil
Administration route: Oral
Indication: Prophylaxis Against Transplant Rejection
Start date: 2005-07-16
End date: 2006-12-01
Other drugs received by patient: Chlormadinone Acetate
|
